ReviewCancer immunology, immunotherapy : CII2026
The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy.
Yilin Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.